Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK’s Advair, Serevent Add “Black Box” On Rare Asthma-Related Deaths

Executive Summary

GlaxoSmithKline has revised labeling for Advair and Serevent to include "black box" warnings on an increased risk of asthma-related deaths in patients taking salmeterol
Advertisement

Related Content

FDA To Conduct Pediatric Safety Analysis for Serevent, Other LABAs
FDA To Conduct Pediatric Safety Analysis for Serevent, Other LABAs
Serevent, Foradil Use With Steroids Should Be Strongly Urged In Labeling
Quarterly Call Round-Up: Pfizer, GSK, Lilly Updates
Quarterly Call Round-Up: Pfizer, GSK, Lilly Updates
Serevent Asthma Safety Signal Is Good News For Advair, GSK Says
GSK Serevent Safety Label Change Coming Soon; Will Advair Be Affected?
GSK Serevent Safety Label Change Coming Soon; Will Advair Be Affected?
Advertisement
UsernamePublicRestriction

Register

PS042324

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel